Management of neonatal herpes simplex virus infection

Paediatric Drugs

Volumn 3, Issue 2, 2001, Pages 81-90

  Kesson, Alison M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; VALACICLOVIR;

CESAREAN SECTION; CLINICAL FEATURE; DRUG EFFICACY; EYE INFECTION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; HYDRATION; INFECTION PREVENTION; KIDNEY FUNCTION; MATERNAL CARE; MORBIDITY; MORTALITY; MOUTH INFECTION; NEWBORN; NEWBORN INFECTION; PATHOGENESIS; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN INFECTION; VERTICAL TRANSMISSION; VIRUS INFECTION;

EID: 0035089526     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103020-00001     Document Type: Review

References (30)

1. Herpes simplex viruses and their replication
2. Herpes simplex virus infections of the central nervous system: Therapeutic and diagnostic considerations
3. Herpes simplex virus infections
4. Low risk of herpes simplex virus in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections
5. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection
6. Neonatal herpes simplex virus infections
7. Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns
8. Transmission of herpes simplex virus type I to a newborn infant during endotracheal suctioning for meconium aspiration
9. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor
10. Genital herpes simplex virus infections: Cinical manifestations, course and complications
11. Empiric therapy with acyclovir for suspected neonatal herpes simplex infections
12. Herpes simplex virus infections of the fetus and newborn
13. Neonatal herpes simplex virus infection: Follow-up evaluation of vidarabine therapy
14. Predictors of morbidity and mortality in neonates with herpes simplex infection
15. Intrauterine herpes simplex virus infections
16. Pharmacokinetics of acyclovir in the term human pregnancy and neonate
17. Acyclovir: A decade later
18. The natural history of herpes simplex virus infections in the mother and neonate
19. Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease
20. Unexpected accumulation of acyclovir in breast milk
21. Monitoring pregnancy outcomes after prenatal drug exposure through prospective registries: A pharmaceutical company commitment
22. The implications of resistance to antiviral drugs for herpes virus drug targets and drug therapy
23. The clinical significance of antiviral drug resistance
24. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS
25. The safety and efficacy of high dose acyclovir in neonatal herpes simplex virus (HSV) infections
26. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus
27. A hypothesis on the pathophysiology of neonatal herpes simplex virus encephalitis: Clinical recurrence after asymptomatic primary infection
28. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
29. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery
30. A randomised placebo controlled trial of suppressive aciclovir in late pregnancy in women with recurrent genital herpes infection